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The Facile and Additive-Free Synthesis of a Cell-Friendly Iron(III)-
Glutathione Complex  
Ziyu Gao,a,b Pablo Carames-Mendez,a Dong Xia,a Christopher M. Pask,a Patrick C. McGowan,a Paul 
A. Bingham,c Alex Scrimshire,c Giuseppe Tronci,*,b,d and Paul D. Thornton*,a 
The straightfoward creation of an unreported glutathione-stabilised iron(III) complex is disclosed. In contrast to 
previous reports, glutathione was shown to coordinate and stabilise iron directly under physiological conditions in the 
absence of additional sulfur containing molecules, such as sodium sulfide. The complex was extensively characterised; 
the molecular geometry was determined as two inequivalent octahedra, approximately 2/3 of which is slightly distorted 
towards more tetrahedral in character, with the remaining 1/3 more regularly octahedral. The dispersion of the iron(III)-
glutathione complex in aqueous solution yielded particles of 255±4 nm in diameter that enhanced the growth and 
proliferation of L929 fibroblast cells over 7 days, and inhibited the activity of matrix metalloproteinase-13. 
Consequently, the unprecedented glutathione-stabilised iron(III) complex disclosed has potential use as a simple-to-
prepare growth factor for inclusion within cell culture media, and is an excellent candidate as a therapeutic for the 
treatment of metalloproteinase-13-associated diseases.    
Introduction  
Glutathione (GSH) is imperative for cellular defence against 
reactive oxygen species that cause apoptosis and tissue 
inflammation.1 Free radicals and reactive oxygen species are 
deactivated by the sulfhydryl moiety that the tripeptide 
presents, undergoing conversion to stable and innocuous 
compounds. Numerous disease states are linked to GSH 
deficiency in cells, including chronic hypertension,2 pulmonary 
fibrosis,3 human immunodeficiency virus-related disease,4 and 
respiratory distress syndrome.5 GSH is administered as an oral 
supplement, however the half-life of GSH within the blood 
plasma (t = 1.6 min) ensures that a significant proportion of the 
supplement is oxidised prior to reaching the gastrointestinal 
tract.6 Consequently, alternative methods of GSH storage and 
localised delivery, or reversible GSH modification, are required 
to elevate depleted tissue GSH levels. 
Transition metal ions perform a number of cellular functions 
within eukaryotes, including photosynthesis and respiration.7 
Metalloproteins, which contain a metal ion cofactor, play a vital 
role in the storage and transport of enzymes and signal 
transduction proteins, and make-up a third of proteins within 
the human body.8 Iron is the most abundant redox-active metal 
within the body owing to its presence within haemoglobin. The 
natural presence of haemoglobin in vivo provides great 
encouragement for the formation of iron-protein and iron-
peptide complexes as materials that are suitable to be deployed 
within living organisms. 
Complexes that contain redox-active metal centres may be 
exploited as therapeutics and diagnostic tools.9 Notably, such 
organometallic materials have been proposed as contrast 
agents in which the variety of oxidation states that the redox-
active metal can adopt is associated with distinct paramagnetic 
properties that enable their effective detection in vivo.10 Iron 
has potential for use within a contrast agent composition due 
to its capability to form high-spin Fe3+ complexes. Wang et al. 
recently reported biochemically responsive Fe2+-PyC3A 
complexes that, upon oxidation by reactive oxygen species, 
form Fe3+-PyC3A that enable contrast enhancement within 
inflamed pancreatic tissue.11 Within healthy tissue, Fe2+-PyC3A 
is maintained and so signal enhancement does not occur. 
GSH has been reported to form stable complexes with 
transition metals including mercury,12 silver,13 cadmium,14 and 
zinc.15 Consequently, it has been cited as a candidate for metal 
speciation in aqueous environments for the detection and 
remedy of heavy metal pollution.16 However, the formation of 
hydrolytically-stable iron-GSH complexes is more limited, 
especially in a cluster-free configuration. Qi et al. reported that 
glutathione-complexed clusters [2Fe-2S] are stabilised by 
glutathione aggregates that form intermolecular salt bridges 
and hydrogen bonds, providing a stable binding pocket for the 
[2Fe-2S] cluster core.17, 18 However, despite these advances, the 
binding of glutathione to ferrous iron in the absence of iron-
sulfur cluster formation has not been reported due to the rapid 
reduction of Fe3+ in the presence of GSH.19, 20. In this case, a 
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complex that contains GSH ligands, but lacks [Fe2S2] bridged 
dimers, is anticipated to form. 
We report the formation of a Fe3+-GSH complex by 
combining equimolar quantities of GSH and FeCl3. Additives that 
promote iron-sulfur cluster formation, for instance sodium 
sulfide, were not included in the synthesis. Analysis reveals that 
reduced GSH forms a complex with Fe3+, yielding a stable 
complex suitable for extensive characterisation. Notably, the 
Fe3+-GSH complex possessed excellent cell compatibility, 
promoting the growth and proliferation of L929 fibroblast cells 
over seven days in vitro. Consequently, it is highly promising as 
a drug-free approach to enhance fibroblast growth in vitro 
within cell culture medium at low concentrations (< 0.5 mg/mL), 
and as a constituent to restore homeostasis in chronic tissue 
states.  
Results and discussion 
To confirm complex formation upon GSH addition to FeCl3 
solution, UV-Vis optical absorption spectroscopy was used to 
track metal-chelate coordination for various molar ratios after 
30 minutes, when the solution colour remained consistent. The 
specific absorbance peak at 456 nm was ascribed to Fe-S 
formation. However, following Fe3+-GSH complex formation, 
two additional absorption peaks were detected at positions of 
452 nm and 550 nm (Figure S1 a) in our system that did not 
present in the spectrum of FeCl3 solution (Figure S2). These 
peaks are attributed to Fe3+-GSH coordination.21, 22 A regular 
decrease in absorbance intensity was observed in solutions 
containing a decreasing molar ratio of FeCl3:GSH (6 → 1), until 
no peak could be detected in solutions containing a molar ratio 
lower than 1 (Figure S1). This observation can be rationalised by 
the fact that when solutions with a FeCl3:GSH molar ratio of 
1ː1.2 or lower were analysed, Fe2+ was present exclusively and 
so no Fe3+-associated absorbance could be recorded, illustrating 
that binding between Fe3+ and GSH occurred only at increased 
FeCl3:GSH molar ratios (i.e. >1). This observation also reveals 
that the thiol-induced reduction of Fe3+ to Fe2+ is expected to 
occur prior to Fe chelation in solutions with increased GSH 
content, and that the chelating interaction detected by UV-Vis 
spectroscopy was exclusively between GSH and Fe3+, rather 
than between GSH and Fe2+, in solutions with decreased GSH 
content. 
Monitoring the colour of the Fe3+-GSH complex-yielding 
solution (FeCl3:GSH= 1:1) revealed that the starting yellow-like 
ferric chloride solution immediately shifted to a dark green 
colour for approximately three seconds upon addition of GSH 
(Figure 1A). The solution then became lighter yellow, in 
comparison with the starting FeCl3 solution, as shown in Figure 
1A. The quick formation of dark green solution is attributed to 
the reduction of Fe3+ to Fe2+, and the oxidation of the GSH thiol, 
whereby either a disulfide bridge forms between two GSH 
molecules, a Fe-S bond forms, or a combination of both may 
form depending on the selected Fe3+:GSH molar ratio (Figure 
1B). As the pH of the solution containing both FeCl3 and GSH is 
acidic (pH < 3), the disulfide bridge may be reduced and Fe2+ 
undergo oxidation after approximately 3 seconds, when the 
light-yellow solution formed. The yellow solution was then 
added to ethanol (Figure 1A (f)), yielding a pale red precipitate 
(Figure 1A (g)), which was dried at 37 °C and further 
characterised. The proposed mechanism for complex formation 
is provided in Figure 1B. The capability of GSSG to induce iron 
oxidation, as shown in step 2, was confirmed by the GSSG-
induced colour change of a FeCl2 solution. The solution shifted 
to a pale red colour that is ascribed to the formation of a Fe3+-
GSH complex (Figure S3). 
The iron valence of the Fe3+-GSH complex was evaluated by 
57Fe Mössbauer spectroscopy at room temperature, 293 K 
(Figure 2). All iron in the complex was confirmed to be Fe3+, with 
no evidence of any magnetically ordered phases.17, 18, 23  
Approximately 60% of the spectral area is consistent with Fe3+ 
with an octahedral structure that is slightly distorted towards 
tetrahedral in character, as evidenced by the relatively low Δ 
(doublet 1, centre shift (δ) = 0.417 mm s-1, quadrupole splitting 
(Δ) = 0.650 mm s-1), 17, 18, 23 and approximately 40% of the 
spectral area is consistent with a more regular octahedral Fe3+ 
structure (doublet 2, δ = 0.447 mm s-1, Δ = 0.987 mm s-1).17, 18, 23 
The 1H-NMR spectrum of the Fe3+-GSH complex is displayed 
in Figure 3, whereby broader peaks can be observed compared 
to the spectrum of GSH. Peak broadening is ascribed to the 
paramagnetism of ferric ions (Fe3+), which affects the magnetic 
field of the instrument. An obvious shift of the CH2-S (position 
c) protons from 2.87 ppm to 2.89 ppm and 3.19 ppm is evident, 
and is attributed to Fe-S binding, as the strong metal-chelate 
coordination affects the neighbouring carbon environment. 
FTIR spectroscopy also revealed differences between the 
spectra of GSH and the Fe3+-GSH complex. A significant shift in 
 
Figure 1 Colour solution change that accompanies the transition of FeCl3 solution to the 
precipitated Fe3+-GSH complex (top) and proposed mechanism of Fe3+-GSH complex 
formation (bottom). 
Figure 2 Fitted Mössbauer spectrum for the Fe3+-GSH complex. 
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the C=O peak position from 1708 cm-1 (GSH) to 1737 cm-1 (Fe3+-
GSH complex) suggests coordination between Fe and 
glutathione hydroxyl oxygen (Figure S4). The peak at 2522 cm-1, 
corresponding to a thiol vibration, disappeared from the 
spectrum of the complex, suggesting Fe-S binding. The peaks at 
3271 cm-1, 1636 cm-1, and 1526 cm-1 correspond to the amine 
groups of GSH. Both 1H NMR and FTIR spectra revealed the 
formation of Fe-S and Fe-O bonds. 
The Fe3+-GSH complex was also found to display specific 
peaks in its CD spectrum (Figure S5). Compared with 
uncoordinated GSH in deionised water, the Fe3+-GSH complex 
presented a broad positive peak from 750 to 460 nm and a 
negative peak from 460 to 302 nm, assigned to Fe3+  
coordination. In 60 mM HCl solution, no obvious structural 
change was observed for the GSH molecule, however, in the 
spectrum of the Fe3+-GSH complex, an abrupt change was 
recorded, whereby the opposite trend was observed, at 750-
422 nm and 422-360 nm, with respect to when the complex was 
incubated in H2O. This change may be due to the presence of 
H+,24 suggesting a reversible pH-induced peptide folding within 
the Fe3+-GSH complex. 
Surface element analysis confirmed the chemical 
composition and the coordinated binding energy of the Fe3+-
GSH powder. GSH powder was used as a control. The elements 
present in the Fe3+-GSH complex are presented in Figure S6, 
which reveals that significant shifts were detected in C=O, C-O 
and S-related bonds (Figure 4). No S-S bond was detected in this 
complex, which would be revealed by a peak at 166 eV, or 
greater.25 The thiol group is protected from forming disulfide 
bridges with other GSH molecules by Fe chelation. In addition, 
no evidence for Fe2+ was found, which would be anticipated to 
appear at 708 ev,26 rather than the pre-peak, which is normally 
observed in Fe related compounds.27 This confirmed the 
exclusive existence of ferric iron, consistent with the results 
from Mössbauer spectroscopy.  
X-ray powder diffraction analysis revealed that 2θ=23.58° 
with a full width at half maximum value of 12.13°, as shown in 
Figure S7. The d spacing of the complex was calculated to be 
0.38 nm, and Dp=0.70 nm. The Fe3+-GSH complex was 
confirmed to possess a 3-layer packing mode, which varied 
markedly to the crystal structure that was obtained for FeCl3 
(Figure S8), confirming that a new stacking structure is formed 
for the Fe3+-GSH complex.  
Figure 4 1H-NMR spectra of Fe3+-GSH complex (black) and GSH (blue) in D2O.  
Figure 3 X-ray photoelectron spectra of the Fe3+-GSH complex and GSH, C1s (a), S2p (b), O1s (c). Fe2p (d) and Fe3p (e) of Fe3+-GSH. 
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UV-Vis fluorescence spectroscopy exposed an emission peak at 
555 nm under excitation wavelength of 408 nm for the Fe3+-GSH 
complex dissolved in deionised water (Figure 5). This peak was 
also present in the spectrum corresponding to a mixture of FeCl3 
and GSH (Figure S9). Upon the addition of HCl to the complex 
solution, the emission peak at 555 nm disappeared. A peak at 
473 nm position formed, which lies between values of pure GSH 
(470 nm) and FeCl3 (493 nm) (Figure S9). The peak at 555 nm is 
considered to result from the strong binding between Fe3+ and 
GSH, yielding a rigid structure that provides a new emission 
peak. Its disappearance after adding HCl suggests that this 
structure is not stable in acidic solution, with the coordination 
between Fe3+ and GSH reduced, as supported by the 
accompanying solution colour change from a turbid pale 
yellow/creamy colour to a transparent colourless solution. 
Thermogravimetric analysis (TGA) was carried out to further 
corroborate the chemical composition and composition of the 
complex. As observed in Figure S10, the first mass loss of 12.0 
% was considered due to water evaporation; the next mass loss 
from 88.0 % to 11.5 %, which commenced at 148.3 °C, is 
ascribed to the loss of GSH. After heating up to 611.8 °C, the 
complex max remained constant at 11.5 %, which was due to 
the presence of iron. Consequently, it was found that the 
complex contains 87 % GSH and 13 % Fe by mass. This is very 
close to the theoretical composition of 84.6 % GSH and 15.4 % 
Fe, based on a total complex mass of 145.4 mg that contains 123 
mg GSH. 
Although Fe was coordinated to water-soluble GSH, the 
solubility of the Fe3+-GSH complex in water remained low due 
to the ionisation equilibrium of Fe itself. Iron ions tend to gain 
hydroxide ligands in neutral and basic water. Mass 
spectrometry analysis revealed peaks at 615 m/z, attributed to 
GSSG, and 308 m/z, attributed to GSH (Figure S11). In contrast 
to mass spectrometry, X-ray photoelectron spectroscopy (XPS) 
investigations revealed the absence of S-S bridges, suggesting 
that the formation of the oxidised product in the mass spectra 
is attributed to the electron source forming ionised species, 
which form GSSG in the instrument channel. Significant 
enhancement in peak intensity was observed after adding 20 μL 
HCl (final concentration of HCl was 120 mM), from 8.9×105 to 
13.2×105 peak intensity at 615 m/z and from 0.8×105 to 5.3×105 
at 308 m/z. The peak at 669 m/z confirms the formation of the 
GS-Fe-SG complex, although its intensity surprisingly increased 
upon the addition of HCl. The enhancement of this peak 
following HCl addition, together with the change in solution 
colour from medium yellow to almost a colourless solution, 
suggested the ionisation of the Fe3+-GSH complex had occurred, 
resulting in the oxidisation of GSH to GSSG, and the partial 
formation of Fe2+ species. 
DLS analysis revealed that the Fe3+-GSH complex was stable 
in water, leading to nanoaggregates with an average effective 
size of 255±4 nm (PDI=0.258±0.015). Following 24-hour storage 
in water, the complex remained well dispersed with an average 
size of 257±2 nm (PDI=0.247±0.008, Figure 6). This 
characteristic may be exploited to generate bespoke Fe3+-GSH 
carriers capable of the prolonged, or redox-mediated, release 
of GSH to, for example, chronic tissues that have downregulated 
levels of GSH.28 
The paramagnetic property of Fe3+-GSH was observed using 
a vibrating-sample magnetometer and increased in magnetic 
moment from -0.1474 emu/g to 0.1474 emu/g under 3 T 
magnetic field, revealing the paramagnetism of the complex 
(Figure S12). 
Following systematic characterisation of the complex, 
attention moved to its applicability within a biological 
environment. Cytotoxicity experiments were carried out with 
L929 mouse fibroblasts and confirmed high cellular tolerability 
of the Fe3+-GSH complex. Growth and proliferation of L929 cells 
were measured during a 7-day culture (Figure 7) with all the 
complex concentrations used in the cell culture medium, 
strongly supporting the excellent complex cytocompatibility 
(Table S1). Even compared with TCPs, only temporary inhibition 
was found in cell proliferation in the first 3 days. After 5-day 
culture, no significant difference could be observed in cell 
growth between cells cultured with either 0.125 mg/mL, 0.25 
mg/mL, 0.5 mg/mL or 0.75 mg/mL of Fe3+-GSH. After 7 days        
Figure 5 UV-Vis fluorescence spectra of the Fe3+-GSH complex in deionised water with a 
concentration of 1.0 mg/mL, initial status (solid) and after adding 20 µL HCl (dash). 
Figure 6 The effective size of Fe3+-GSH in H2O at a concentration of 0.5 mg/mL, initial 
status (solid) and storage in water for 24 hours (dash). 
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culture, L929 cells in 0.125 mg/mL presented significant higher 
viability and no significant difference was found at 0.25 mg/mL 
and 0.5 mg/mL conditions. The complex is described as being 
‘cell-friendly’ due the positive effect that it has on cell growth 
when included in the assessed cell culture medium at 0.125 
mg/mL, and due to it being non-cytotoxic when included in the 
assessed cell culture medium at concentrations ≤ 0.5 mg/mL. 
Conversely, when high Fe3+-GSH content (> 0.5 mg/mL) was 
supplemented to the cell culture medium, cells proved to grow 
slower with respect to cells cultured on tissue 
culture polystyrene (TCPs), suggesting a significant GSH-
induced impact on cellular activity at increased complex 
concentrations. In addition to possessing cellular tolerability, 
the Fe3+-GSH complex proved also to be stable following 24-
hour incubation in cell culture medium, suggesting long-lasting 
GSH storing capability (Figure S13 a-d) and potential 
applicability as magnetic resonance contrast agent. 
The effect of the complex on matrix metalloproteinase-13 
(MMP-13) activity was then assessed to determine the 
effectiveness of the material as a viable therapeutic for ailments 
in which MMP-13 is overexpressed. Studies revealed that MMP-
13 activity decreased to 80±7 % after 12-hour incubation in the 
presence of the complex (Figure 8). After 48 hours incubation, 
MMP-13 activity was downregulated to 74±1 %. A significant 
difference was shown at all time points compared with the 
MMP-13 group, in which no complex was included. In addition, 
no significant difference was observed in the GSH group 
signifying the requirement of both organic and inorganic 
components for effective enzyme inhibition. This quick and 
lasting downregulation proved the ability of the Fe3+-GSH 
complex to inhibit MMP-13 activity and suggested great 
potential for the complex to be applied to inflammation, 
wound, and arthritis management by downregulating MMP 
activity. 
 
Conclusions 
The formation of a Fe3+-GSH complex without sulfur within its 
structure is reported and characterised for the first time. 
Aggregate formation of the complex in water yielded stable 
particulates with an initial average effective size of 255±4 nm. 
Such aggregates dispersed in aqueous solution and were found 
to be non-cytotoxic against L929 fibroblast cells. Fibroblast 
growth and proliferation was enhanced versus TCP after seven 
days of cell culture, suggesting that the material has great 
potential for use as a growth factor in cell culture medium. 
Additionally, the complex reduced the activity of MMP-13 over 
48 hours, rendering it a highly promising candidate as a 
treatment for MMP-13-associated conditions. 
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Figure 7 L929 cell viability without/with Fe3+-GSH complex for 7 days culture. 
Figure 8 MMP-13 activity following incubation with Fe3+-GSH or GSH for (a) 12 hours, 
(b) 24 hours, (c) 48 hours. 
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Notes and references 
‡Supporting information. The following supporting information 
is available free of charge: spectra corresponding to UV-Vis 
absorption spectroscopy, FTIR, mass spectrometry, XPS, X-ray 
powder diffraction, UV-Vis fluorescence spectroscopy, and TGA. 
Vibrating-sample magnetometer data, cell culture images and 
statistical analysis of cell viability are also provided. 
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The straightforward creation of an unreported glutathione-stabilised iron(III) complex that enhances 
L929 fibroblast cell viability, and inhibits matrix metalloproteinase-13 activity is described.
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